Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

1-O-palmitylglucuronic acid

Known as: 1-O-palmityl-D-glucuronic acid, PGlcUA, palmitoyl glucuronide 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Abstract Phospholipids and cholesterols are being spotlighted as raw materials for preparing liposomes, one of the key compounds… Expand
1998
1998
We previously synthesized the 5'-O-diacylphosphatidyl derivative of 2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine… Expand
1996
1996
Various kinds of long-circulating liposome, such as ganglioside GM1-, polyethyleneglycol- (PEG-), and glucuronide-modified… Expand
1996
1996
Liposomes modified with the uronic acid derivative palmityl-D-glucuronide (PGlcUA) have a long circulation time and tend to… Expand
1995
1995
Long-circulating liposomes are known to accumulate passively in tumor tissues of tumor-bearing animals. To evaluate the in vivo… Expand
1994
1994
Long‐circulating liposomes modified with a uronic‐acid derivative, palmityl‐D‐glucuronide (PGIcUA), have been developed… Expand
1994
1994
Reticuloendothelial system (RES)-avoiding liposomes are known to accumulate in tumor tissues due to passive targeting… Expand
1993
1993
For passive targeting of liposomes to tumor tissues, we earlier developed reticuloendothelial system (RES)-avoiding liposomes… Expand
Highly Cited
1992
Highly Cited
1992
For passive targeting of liposomes to tumor tissues, we earlier developed reticuloendothelial system (RES)-avoiding liposomes… Expand
1992
1992
For overcoming rapid removal of liposomes from the bloodstream, we developed reticuloendothelial system (RES)-avoiding liposomes… Expand